
Neoantigen Targeted Therapies Global Market Report 2025
Description
Neoantigen Targeted Therapies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on neoantigen targeted therapies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for neoantigen targeted therapies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neoantigen targeted therapies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Monotherapy, Combination Therapy
2) By Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies
3) By Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer
4) By Route Of Administration: Intradermal, Intravenous, Subcutaneous
5) By Application: Medical Research Institution, Hospital, And Clinic, Other Applications
Subsegments:
1) By Monotherapy: Individual Neoantigen-Targeted Treatments
2) By Combination Therapy: Neoantigen-Targeted Therapies Combined With Other Immunotherapies; Neoantigen-Targeted Therapies Combined With Chemotherapy; Neoantigen-Targeted Therapies Combined With Targeted Therapies
Companies Mentioned: F. Hoffmann-La Roche AG; Merck and Co. Inc.; Bristol Myers Squibb Company; Eli Lilly and Company; Kite Pharma Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on neoantigen targeted therapies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for neoantigen targeted therapies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neoantigen targeted therapies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Monotherapy, Combination Therapy
2) By Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies
3) By Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer
4) By Route Of Administration: Intradermal, Intravenous, Subcutaneous
5) By Application: Medical Research Institution, Hospital, And Clinic, Other Applications
Subsegments:
1) By Monotherapy: Individual Neoantigen-Targeted Treatments
2) By Combination Therapy: Neoantigen-Targeted Therapies Combined With Other Immunotherapies; Neoantigen-Targeted Therapies Combined With Chemotherapy; Neoantigen-Targeted Therapies Combined With Targeted Therapies
Companies Mentioned: F. Hoffmann-La Roche AG; Merck and Co. Inc.; Bristol Myers Squibb Company; Eli Lilly and Company; Kite Pharma Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Neoantigen Targeted Therapies Market Characteristics
- 3. Neoantigen Targeted Therapies Market Trends And Strategies
- 4. Neoantigen Targeted Therapies Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
- 5. Global Neoantigen Targeted Therapies Growth Analysis And Strategic Analysis Framework
- 5.1. Global Neoantigen Targeted Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Neoantigen Targeted Therapies Market Growth Rate Analysis
- 5.4. Global Neoantigen Targeted Therapies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Neoantigen Targeted Therapies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Neoantigen Targeted Therapies Total Addressable Market (TAM)
- 6. Neoantigen Targeted Therapies Market Segmentation
- 6.1. Global Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Monotherapy
- Combination Therapy
- 6.2. Global Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- DNA Or RNA-Based Vaccines
- Protein-Based Vaccines
- Dendritic Cell Vaccines
- TIL-Based Therapies
- 6.3. Global Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Colorectal Cancer
- Renal Cell Carcinoma
- Non-Small Cell Lung Cancer
- Bone Cancer
- Gynecological Cancer
- 6.4. Global Neoantigen Targeted Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Intradermal
- Intravenous
- Subcutaneous
- 6.5. Global Neoantigen Targeted Therapies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Medical Research Institution
- Hospital And Clinic
- Other Applications
- 6.6. Global Neoantigen Targeted Therapies Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Individual Neoantigen-Targeted Treatments
- 6.7. Global Neoantigen Targeted Therapies Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neoantigen-Targeted Therapies Combined With Other Immunotherapies
- Neoantigen-Targeted Therapies Combined With Chemotherapy
- Neoantigen-Targeted Therapies Combined With Targeted Therapies
- 7. Neoantigen Targeted Therapies Market Regional And Country Analysis
- 7.1. Global Neoantigen Targeted Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Neoantigen Targeted Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Neoantigen Targeted Therapies Market
- 8.1. Asia-Pacific Neoantigen Targeted Therapies Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Neoantigen Targeted Therapies Market
- 9.1. China Neoantigen Targeted Therapies Market Overview
- 9.2. China Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Neoantigen Targeted Therapies Market
- 10.1. India Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Neoantigen Targeted Therapies Market
- 11.1. Japan Neoantigen Targeted Therapies Market Overview
- 11.2. Japan Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Neoantigen Targeted Therapies Market
- 12.1. Australia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Neoantigen Targeted Therapies Market
- 13.1. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Neoantigen Targeted Therapies Market
- 14.1. South Korea Neoantigen Targeted Therapies Market Overview
- 14.2. South Korea Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Neoantigen Targeted Therapies Market
- 15.1. Western Europe Neoantigen Targeted Therapies Market Overview
- 15.2. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Neoantigen Targeted Therapies Market
- 16.1. UK Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Neoantigen Targeted Therapies Market
- 17.1. Germany Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Neoantigen Targeted Therapies Market
- 18.1. France Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Neoantigen Targeted Therapies Market
- 19.1. Italy Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Neoantigen Targeted Therapies Market
- 20.1. Spain Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Neoantigen Targeted Therapies Market
- 21.1. Eastern Europe Neoantigen Targeted Therapies Market Overview
- 21.2. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Neoantigen Targeted Therapies Market
- 22.1. Russia Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Neoantigen Targeted Therapies Market
- 23.1. North America Neoantigen Targeted Therapies Market Overview
- 23.2. North America Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Neoantigen Targeted Therapies Market
- 24.1. USA Neoantigen Targeted Therapies Market Overview
- 24.2. USA Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Neoantigen Targeted Therapies Market
- 25.1. Canada Neoantigen Targeted Therapies Market Overview
- 25.2. Canada Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Neoantigen Targeted Therapies Market
- 26.1. South America Neoantigen Targeted Therapies Market Overview
- 26.2. South America Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Neoantigen Targeted Therapies Market
- 27.1. Brazil Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Neoantigen Targeted Therapies Market
- 28.1. Middle East Neoantigen Targeted Therapies Market Overview
- 28.2. Middle East Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Neoantigen Targeted Therapies Market
- 29.1. Africa Neoantigen Targeted Therapies Market Overview
- 29.2. Africa Neoantigen Targeted Therapies Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Neoantigen Targeted Therapies Market, Segmentation By Immunotherapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Neoantigen Targeted Therapies Market, Segmentation By Target Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Neoantigen Targeted Therapies Market Competitive Landscape And Company Profiles
- 30.1. Neoantigen Targeted Therapies Market Competitive Landscape
- 30.2. Neoantigen Targeted Therapies Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Kite Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
- 31. Neoantigen Targeted Therapies Market Other Major And Innovative Companies
- 31.1. Gilead Sciences Inc.
- 31.2. Amgen Inc.
- 31.3. Moderna Inc.
- 31.4. BioNTech SE
- 31.5. Bavarian Nordic Inc.
- 31.6. Advaxis Inc.
- 31.7. Immatics NV
- 31.8. Precision Biologics Inc.
- 31.9. Iovance Biotherapeutics Inc.
- 31.10. Agenus Inc.
- 31.11. Achilles Therapeutics Plc
- 31.12. Medigene AG
- 31.13. Gritstone Bio Inc.
- 31.14. SQZ Biotechnologies Company
- 31.15. Aduro BioTech Inc.
- 32. Global Neoantigen Targeted Therapies Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Neoantigen Targeted Therapies Market
- 34. Recent Developments In The Neoantigen Targeted Therapies Market
- 35. Neoantigen Targeted Therapies Market High Potential Countries, Segments and Strategies
- 35.1 Neoantigen Targeted Therapies Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Neoantigen Targeted Therapies Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Neoantigen Targeted Therapies Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.